Check back often to find the latest news on AgeneBio and our pipeline of multiple candidates.
March 11, 2015
Trial Shows Current Drug Slows Alzheimer’s Onset
A clinical trial testing a current drug to treat epilepsy shows the drug can delay development of Alzheimer’s disease in its earliest stages. Results of the study, conducted by researchers at Johns Hopkins University for AgeneBio Inc., two year-old pharmaceutical company in Baltimore, appear online in the journal NeuroImage: Clinical…
